期刊文献+

老年性心力衰竭患者血清cTnI与血浆BNP联合检测的临床意义 被引量:4

Clinical significance of combined detection of serum cTnI and plasma BNP in elderly patients with heart failure
下载PDF
导出
摘要 目的:探讨老年性心力衰竭患者血清cTnI与血浆BNP联合检测的临床意义。方法:收治老年心衰患者100例作为观察组,选择同期健康体检的老年人100例作为对照组,均检测BNP和cTnI。结果:观察组血清cTnI浓度和血浆BNP浓度明显高于对照组,差异有统计学意义(P<0.05);随心功能分级级别的增高而增高,心功能分级不同,血清cTnI浓度和血浆BNP浓度也有显著的差异,差异有统计学意义(P<0.05)。结论:BNP和cTnI的浓度在CHF患者中均升高,与心衰程度呈正相关。BNP和cTnI的联合检测是评价老年心衰的重要指标,对判断患者心功能的状况有较高的临床价值。 Objective:To explore the clinical significance of combined detection of serum cTnI and plasma BNP in elderly patients with heart failure.Methods:100 elderly patients with heart failure were selected as the observation group,and 100 healthy elderly people were selected as the control group,both BNP and cTnI were detected.Results:The serum cTnI concentration and plasma BNP concentration in the observation group were significantly higher than those in the control group,and the difference was statistically significant(P〈0.05).Increased with heart function classification level,there were significant differences in serum cTnI concentration and plasma BNP concentration in patients with different cardiac function grades,and the difference was statistically significant(P〈0.05).Conclusion:The concentrations of BNP and cTnI are increased in patients with CHF,and positively correlated with the degree of heart failure.The combined detection of BNP and cTnI is an important indicator for the evaluation of elderly heart failure,and has a high clinical value in judging the cardiac function of the patients.
作者 朱利君
出处 《中国社区医师》 2017年第35期122-122,124,共2页 Chinese Community Doctors
关键词 老年性心力衰竭 CTNI BNP 联合检测 Elderly heart failure cTnI BNP Combined detection
  • 相关文献

参考文献3

二级参考文献27

  • 1James L,Garlos A,Saif A,et al.The N-Terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study[J].Am J Cardiol,2005,95(8):948-954.
  • 2Pearson T,Mensah G,Alexander R,et al.Markers of inflammation and cardiovascular disease-application to clinical and public health practice:a statement for heahhcare professionals from the Centers for Disease Control and Prevention and the American Heart Assoeiation[J].Circulation,2003,107(3):499-511.
  • 3Pfister R,Tan D,Thekkanal J,et al.Predictive value of NT-pro-BNP for the non-cardiologist.A study on 573 hospitalized patients with cardiovascular disease[J].Dtsch Med Wochenschr,2008,133(12):564-569.
  • 4Omland T,de Lemos JA,Sabatine MS,et al.A sensitive cardiac troponin Tassay in stable coronary artery disease[J].N Engl J Med,2009,361(26):2538-2547.
  • 5De Ferranti SD,Rifai N.C-reactive protein and cardiovascular disease:a freview of risk prediction and interventions[J].Clin Chim Acta,2002,317(1-2):1-15.
  • 6Dinh W,Nickl W,Füth R,et al.High sensitive troponin T and heart fatty acid binding protein:novel biomarker in heart failure with normal ejection fraction?:a cross-sectional study[J].BMC Cardiovasc Disord,2011,11:41.
  • 7Rehman SU,Mueller T,Januzzi JL Jr.Characteristics of the novel interleukin family biomarker ST2 in patients with acute heart failure[J].J Am Coll Cardiol,2008,52 (18):1458-1465.
  • 8Bayes-Genis A,Pascual-Figal D,Januzzi JL,et al.Soluble ST2 monitoring provides additional risk stratification for outpa-tients with decompensated heart failure[J].Rev Esp Cardiol,2010,63 (10):1171-1178.
  • 9Pascual-Figal DA,Ordo(n)ez-Llanos J,et al.Soluble ST2 for predicting sudden cardiac death in patients with chronic heart failure and left ventricular systolic dysfunction[J].J Am Coll Cardiol,2009,54 (23):2174-2179.
  • 10Miller AM,Liew FY.The IL-33/ST2 pathway-A new thera-peutic target in cardiovascular disease[J].Pharmacol Ther,2011,131 (2):179-186.

共引文献43

同被引文献57

引证文献4

二级引证文献67

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部